UK’s fastest and approved COVID-19 Tests by healthcare experts
WORLD LEADING DIAGNOSTICS SERVICES
Protein Technologies Ltd
Protein Technologies Ltd. (PTL) is an award-winning, biotech company established in 2010. The company provides contract research services to the biotech industry.
Since its conception it has received multiple awards and funding from the UK government’s Technology Strategy Board (now Innovate UK), Bill and Melinda Gates Foundation and The Wellcome Trust for its innovation in biotechnology.
PTL is a world-leading innovator in the fields of recombinant proteins, protein engineering, biotherapeutics, biosensors, and bioreactors. PTL operates from state-of-the-art laboratories at Manchester Science Park in the United Kingdom.
World’s first ice-crystal biosensor for use in the shipment of vaccines, biotherapeutics and regenerative medicine products.
A cancer drug that emits in the infrared spectrum for use as a diagnostic and photodynamic therapy for breast cancer.
Revolutionary hand-held device for identification of drugs and ‘bioinks’ for track and trace and environmental monitoring system offering unparalleled levels of security, traceability and quality assurance.
For novel fluorescent proteins in the coral triangle - a two year joint development project with Sabah Biodiversity Centre, Malaysia.
2015: Rare Disease
Therapy - Welcome Trust-A novel Enzyme Replacement Therapy (ERT) for sufferers of a rare disease called Alkaptonuria (AKU) otherwise known as black bone disease. AKU was the first genetic disease identified by Garrod in 1902.